Woburn drug maker may stop making sterile injections

in 2013, Boston Globe, Kevin Outterson, Newsmakers, School of Law
April 3rd, 2013

outterson_white-new_65wBoston Globe (subscription required)
Kevin Outterson, School of Law

The owner of a Woburn specialty pharmacy that recalled two dozen drugs after the discovery of ­unidentified contaminants told regulators Tuesday that he was uncertain whether he would continue mixing sterile injectable medications and eye solutions, the riskiest kind of compounded drugs…

View full article

Comments are closed.